Shares of Immix Biopharma, Inc. (IMMX) are up 17% on Thursday due to the announcement that the FDA has designated NXC-201 as an Orphan Drug Designation (ODD) for the treatment of Amyloid Light Chain (AL) Amyloidosis, a life-threatening blood disorder.
Shares of Harmony Biosciences Holdings, Inc. (HRMY) are up 4% on Thursday after the company's Pitolisant Tablets was granted FDA Orphan Drug designation for the treatment of idiopathic hypersomnia (IH), a rare and chronic neurological disease that is characterized by excessive daytime sleepiness.
Zydus to present on ZYIL1 at the International Congress of Parkinson s Disease and Movement Disorders® equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Biopharmaceutical company Nuvectis Pharma, Inc. (NVCT) announced Thursday that NXP800 was granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of cholangiocarcinoma.